SFRS18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.491600E-01
Normal-vs-Stage2
3.723200E-01
Normal-vs-Stage3
3.041400E-01
Normal-vs-Stage4
4.201000E-01
Stage1-vs-Stage2
2.466800E-01
Stage1-vs-Stage3
8.893800E-02
Stage1-vs-Stage4
8.032600E-01
Stage2-vs-Stage3
2.389200E-01
Stage2-vs-Stage4
5.488200E-01
Stage3-vs-Stage4
1.082780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.802000E-01
Normal-vs-AfricanAmerican
3.334400E-01
Normal-vs-Asian
3.326200E-01
Caucasian-vs-AfricanAmerican
3.508400E-01
Caucasian-vs-Asian
2.038400E-01
AfricanAmerican-vs-Asian
9.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.711400E-01
Normal-vs-Female
3.781600E-01
Male-vs-Female
7.199800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.220600E-01
Normal-vs-Age(41-60Yrs)
3.939800E-01
Normal-vs-Age(61-80Yrs)
3.648000E-01
Normal-vs-Age(81-100Yrs)
3.619400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.689000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.765000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.404400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.873980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.419000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.678200E-01
Normal-vs-Daily Drinker
3.423600E-01
Normal-vs-Weekly Drinker
3.430400E-01
Normal-vs-Occasional Drinker
4.052200E-01
Normal-vs-Social Drinker
3.891000E-01
Non Drinker-vs-Daily Drinker
3.994000E-01
Non Drinker-vs-Weekly Drinker
4.688000E-01
Non Drinker-vs-Occasional Drinker
5.472400E-01
Non Drinker-vs-Social Drinker
5.835400E-01
Daily Drinker-vs-Weekly Drinker
9.829600E-01
Daily Drinker-vs-Occasional Drinker
2.738000E-01
Daily Drinker-vs-Social Drinker
1.734380E-01
Weekly Drinker-vs-Occasional Drinker
2.820000E-01
Weekly Drinker-vs-Social Drinker
2.001800E-01
Occasional Drinker-vs-Social Drinker
8.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.417560E-01
Normal-vs-Grade 2
8.356200E-02
Normal-vs-Grade 3
5.245800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.735400E-01
Grade 1-vs-Grade 3
6.017400E-01
Grade 1-vs-Grade 4
1.417560E-01
Grade 2-vs-Grade 3
9.487400E-01
Grade 2-vs-Grade 4
8.356200E-02
Grade 3-vs-Grade 4
5.245800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.589000E-01
Normal-vs-NonDiabetic
3.660800E-01
Diabetic-vs-NonDiabetic
7.285600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.522200E-01
Normal-vs-NoPancreatitis
3.631000E-01
Pancreatitis-vs-NoPancreatitis
7.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.799200E-01
Normal-vs-N1
3.704400E-01
N0-vs-N1
6.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.409600E-01
Normal-vs-TP53-NonMutant
4.227600E-01
TP53-Mutant-vs-TP53-NonMutant
4.737300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
